secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2026-04-14T23:59:59+00:00
Accession:  0001213900-26-043239
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne to effect 1-for-6 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------

- Board approved 1-for-6 reverse stock split, effective 5:00 p.m. ET on April 15, 2026.
- Trading on Nasdaq will commence on split-adjusted basis under symbol NMTC on April 16, 2026.
- No fractional shares; stockholders entitled to cash payment for fractional interests.
- Reverse split intended to increase bid price and regain compliance with Nasdaq minimum bid rule.
- Authorized shares and par value unchanged; CUSIP changes to 64130M308.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026043239/0001213900-26-043239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026043239/ea0286106-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-043239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer